Skip to main content

KabiCare Patient Support Program forIDACIO® (adalimumab-aacf)

Idacio Box Packaging for 40mg/0.8mL 2 Single-Dose Prefilled PensIDACIO® (adalimumab-aacf) is an FDA-approved biosimilar to Humira® (adalimumab) that addresses patients’ and prescribers’ core needs.1

First approved in 2019, and already available in nearly 40 countries around the world, IDACIO is indicated to reduce the signs and symptoms of moderate to severe:

  • Rheumatoid arthritis in adults
  • Polyarticular juvenile idiopathic arthritis in children age 2 years or older
  • Psoriatic arthritis in adults
  • Ankylosing spondylitis in adults
  • Crohn’s disease in adults and children age 6 years or older
  • Chronic plaque psoriasis in adults
  • Ulcerative colitis in adults
  • Hidradenitis suppurativa in adults
  • Uveitis in adults

Learn More About Idacio (Opens in a New Window)

For more information about Biosimilars please visit our website: BioSpecialized (Opens in a New Window)

Reference 1: IDACIO (adalimumab-aacf) injection prescribing information. Lake Zurich, IL: Fresenius Kabi USA, LLC; 2023

Please see the Full Prescribing Information, including the boxed WARNING, for IDACIO (adalimumab-aacf) (PDF Opens in a New Window).
Please see the Full Prescribing Information, including the boxed WARNING, for ADALIMUMAB-AACF – This product is IDACIO® (adalimumab-aacf)(PDF Opens in a New Window).

Important Safety Information

Program Support Areas

Learn more about the program support for IDACIO offered through KabiCare by selecting an area of support below:

KabiCare is here to offer you support and assistance, from diagnosis through your treatment and care.

There are several ways to enroll in the programs provided by KabiCare. Your healthcare provider can enroll you in the KabiCare Patient Support Program, or you can download the enrollment form (PDF Opens in a New Window) and begin completing it yourself. Your completed enrollment form can be submitted to KabiCare online, by phone, or by fax. Once enrolled, you can opt-in for Nurse Support and note any communication preferences that the KabiCare Patient Support Guide should be aware of.

Click here to download the enrollment form. (PDF Opens in a New Window)

Who is Your Patient Support Guide?

Your KabiCare Patient Support Guide is someone who will be available to support you through the enrollment process and will work closely with you and your healthcare provider(s) to help navigate your insurance, financial assistance, and medication access needs to simplify your treatment journey. Getting answers to your questions is just a phone call away at 1-833-KABICARE (1-833-522-4227)

Welcome Packet

A Welcome Packet will be mailed or emailed to you once enrollment is complete. Inside the kit you will find important information about IDACIO and the KabiCare Patient Support Program. You will also receive a Welcome Call from a program Nurse Educator who will review the Welcome Packet materials with you and help answer questions about IDACIO.

How to enroll

KabiCare can help you navigate insurance processes and provide information related to your insurance coverage. After enrollment in KabiCare is complete and you have received a Welcome Call from a Nurse Educator, you will have an opportunity to speak with your Patient Support Guide at a time convenient for you to review your benefits and discuss other patient support program offerings you may be eligible to receive. Your Patient Support Guide is trained to assist you with questions about the KabiCare support programs available to you.

KabiCare can also help make sure your prescription gets to the right specialty pharmacy based on your healthcare provider’s preference or your insurance plan requirements.

Bridge to Therapy Program

The Bridge to Therapy Program ensures that you can receive IDACIO without delay while you are waiting for insurance approval. Eligibility* criteria apply.

*Eligibility criteria apply. Patients are not eligible for Bridge to Therapy Program support if the prescription is eligible to be reimbursed, in whole or in part, by any state or federal healthcare program.

KabiCare can help with enrolling you into additional assistance programs.

Commercial Copay Support

If you have commercial or private insurance, you may be eligible* for the copay program that lowers your out-of-pocket costs to as little as $0/month for treatment with an annual maximum.

Learn more about the copay program or enroll in copay ONLY

Patient Assistance Program

If you do not have insurance and/or cannot afford your medication, you may be eligible for additional assistance through the Patient Assistance Program** or through independent nonprofit patient assistance programs. Eligibility criteria apply.‡

*Eligibility criteria apply. Patients are not eligible for commercial copay assistance if the prescription is eligible to be reimbursed, in whole or in part, by any state or federal healthcare program.

**Terms and Conditions apply.

‡Eligibility for resources provided by independent nonprofit patient assistance programs is based on the nonprofits’ criteria. Fresenius Kabi has no control over these programs.

Financial Assistance Resources

Non-Profit Foundations for Financial Assistance

Nurse Support

Once you are enrolled, KabiCare Nurse Educators are available to help you understand your disease, treatment, and prescribed medication. They can provide additional educational resources and virtual or in-person injection training if needed. You can also view an injection training video at www.idacio.com (Opens in a New Window).

Nurse support provided by KabiCare is not meant to replace discussions with your healthcare provider regarding your care and treatment.

Why Enroll in KabiCare?

KabiCare is here to offer you support and assistance, from diagnosis through your treatment and care.

There are several ways to enroll in the programs provided by KabiCare. Your healthcare provider can enroll you online in the KabiCare Patient Support Program or by fax. Once enrolled, patients can note any communication preferences that the KabiCare Patient Support Guide should be aware of.

Talk to your doctor today about enrolling in KabiCare.

Expand

Important Safety Information About IDACIO® (adalulimab-aacf)

What is the most important information I should know about IDACIO®(adalulimab-aacf)?

You should discuss the potential benefits and risks of IDACIO® with your healthcare provider. IDACIO® is a TNF blocker medicine that affects your immune system. IDACIO® can lower the ability of your immune system to fight infections.

  • Serious infections have happened in people taking IDACIO®. These serious infections include tuberculosis (TB) and infections caused by viruses, fungi, or bacteria that have spread throughout the body. Some people have died from these infections. Your healthcare provider should test you for TB before starting IDACIO®. Your healthcare provider should check you closely for signs and symptoms of TB during treatment with IDACIO®. You should not start taking IDACIO® if you have any kind of infection unless your healthcare provider says it is okay.
  • Cancer. For children and adults taking TNF blockers, including IDACIO®, the chance of getting lymphoma or other cancers may increase. There have been cases of unusual cancers in children, teenagers, and young adults using TNF blockers. Some people have developed a rare type of cancer called hepatosplenic T-cell lymphoma. This type of cancer often results in death. If using TNF blockers including IDACIO®, your chance of getting two types of skin cancer (basal cell and squamous cell) may increase. These types are generally not life-threatening if treated; tell your healthcare provider if you have a bump or open sore that doesn’t heal.

What should I tell my healthcare provider BEFORE starting IDACIO®?

Tell your healthcare provider about all of your health conditions, including if you:

  • Have an infection, are being treated for infection, or have symptoms of an infection
  • Get a lot of infections or infections that keep coming back
  • Have diabetes
  • Have TB or have been in close contact with someone with TB
  • Live or have lived in an area (such as the Ohio and Mississippi River valleys) where there is an increased risk for getting certain kinds of fungal infections, such as histoplasmosis, coccidioidomycosis, or blastomycosis. These infections may happen or become more severe if you use IDACIO®. Ask your healthcare provider if you are unsure if you have lived in these areas
  • Have or have had hepatitis B
  • Have or had heart failure
  • Have or had cancer
  • Have any numbness or tingling or have a disease that affects your nervous system such as multiple sclerosis or Guillain-Barré syndrome.
  • Have recently received or are scheduled to receive a vaccine. You may receive vaccines, except for live vaccines. Children should be brought up to date on all vaccines before starting IDACIO®.
  • Are scheduled for major surgery
  • Are allergic to IDACIO® or to any of its ingredients.
  • Are pregnant or plan to become pregnant, breastfeeding or plan to breastfeed. You and your healthcare provider should decide if you should take IDACIO® while you are pregnant or breastfeeding.
  • Have a baby and you were using IDACIO® during your pregnancy. Tell your baby’s healthcare provider before your baby receives any vaccines.

Also tell your healthcare provider about the medications you take. You should not take IDACIO® with ORENCIA® (abatacept), KINERET® (anakinra), REMICADE® (infliximab), ENBREL® (etanercept), CIMZIA® (certolizumab pegol), or SIMPONI® (golimumab). Tell your healthcare provider if you have ever used RITUXAN® (rituximab), IMURAN® (azathioprine), or PURINETHOL® (mercaptopurine, 6-MP).

What should I watch for AFTER starting IDACIO®?

After starting IDACIO®, call your healthcare provider right away if you have an infection, or any sign of an infection. IDACIO® can make you more likely to get infections or make any infection that you may have worse.

IDACIO® can cause serious side effects, including:

  • Serious infections. Your healthcare provider will examine you for TB and perform a test to see if you have TB. If your healthcare provider feels that you are at risk for TB, you may be treated with medicine for TB before you begin treatment with IDACIO® and during treatment with IDACIO®. Even if your TB test is negative your healthcare provider should carefully monitor you for TB infections while you are taking IDACIO®. People who had a negative TB skin test before receiving adalimumab products have developed active TB. Tell your healthcare provider if you have any of the following symptoms while taking or after taking IDACIO®:
    • Cough that does not go away
    • Weight loss
    • Low grade fever
    • Loss of body fat and muscle (wasting)
  • Hepatitis B infection in carriers of the virus. If you are a carrier of the hepatitis B virus (a virus that affects the liver), the virus can become active while you use IDACIO®. Your healthcare provider should do blood tests before you start treatment, while you are using IDACIO®, and for several months after you stop treatment with IDACIO®. Tell your healthcare provider if you have any of the following symptoms of a possible hepatitis B infection:
    • Muscle aches
    • Feel very tired
    • Dark urine
    • Skin or eyes look yellow
    • Little or no appetite
    • Vomiting
    • Clay-colored bowel movements
    • Fever
    • Chills
    • Stomach discomfort
    • Skin rash
  • Allergic reactions. Allergic reactions can happen in people who use IDACIO®. Call your healthcare provider or get medical help right away if you have any of these symptoms of a serious allergic reaction:
    • Hives
    • Trouble breathing
    • Swelling of your face, eyes, lips or mouth
  • Nervous system problems. Signs and symptoms of a nervous system problem include numbness or tingling, problems with your vision, weakness in your arms or legs, and dizziness.
  • Blood problems. Your body may not make enough of the blood cells that help fight infections or help to stop bleeding. Symptoms include a fever that does not go away, bruising or bleeding very easily, or looking very pale.
  • Heart Failure (new or worsening) Symptoms include shortness of breath, swelling of your ankles or feet, and sudden weight gain.
  • Immune reactions including a lupus-like syndrome. Symptoms include chest discomfort or pain that does not go away, shortness of breath, joint pain, or a rash on your cheeks or arms that gets worse in the sun. Symptoms may improve when you stop IDACIO®.
  • Liver problems. Liver problems can happen in people who use TNF-blocker medicines. These problems can lead to liver failure and death. Call your healthcare provider right away if you have any of these symptoms:
    • Feel very tired
    • Poor appetite or vomiting
    • Skin or eyes look yellow
    • Pain on the right side of your stomach (abdomen)
  • Psoriasis. Some people using adalimumab products had new psoriasis or worsening of psoriasis they already had. Tell your healthcare provider if you develop red scaly patches or raised bumps that are filled with pus. Your healthcare provider may decide to stop your treatment with IDACIO®.

Call your healthcare provider or get medical care right away if you develop any of the above symptoms. Your treatment with IDACIO® may be stopped.

Common side effects of IDACIO® include injection site reactions (pain, redness, rash, swelling, itching, or bruising), upper respiratory infections (sinus infections), headaches, rash, and nausea. These are not all the possible side effects with IDACIO®. Tell your doctor if you have any side effect that bothers you or that does not go away.

These are not all the possible side effects with IDACIO®. Tell your healthcare provider if you have any side effect that bothers you or that does not go away.

Remember, tell your doctor right away if you have an infection or symptoms of an infection, including:

  • Fever, sweats, or chills
  • Muscle aches
  • Cough
  • Shortness of breath
  • Blood in phlegm
  • Weight loss
  • Warm, red, or painful skin or sores on your body
  • Diarrhea or stomach pain
  • Burning when you urinate
  • Urinating more often than normal
  • Feeling very tired

IDACIO® is given by injection under the skin.

This is the most important information to know about IDACIO®. For more information, talk to your health care provider.

Uses

IDACIO®is a prescription medicine used:

  • To reduce the signs and symptoms of:
    • Moderate to severe rheumatoid arthritis (RA) in adults. IDACIO® can be used alone, with methotrexate, or with certain other medicines. IDACIO® may prevent further damage to your bones and joints and may help your ability to perform daily activities.
    • Moderate to severe polyarticular juvenile idiopathic arthritis (JIA) in children 2 years of age and older. IDACIO® can be used alone or with methotrexate.
    • Psoriatic arthritis (PsA) in adults. IDACIO® can be used alone or with certain other medicines. IDACIO® may prevent further damage to your bones and joints and may help your ability to perform daily activities.
    • Ankylosing spondylitis (AS) in adults.
    • Hidradenitis Suppurativa (HS): treatment of moderate to severe hidradenitis suppurativa in adults.
  • To treat moderate to severe Crohn’s disease (CD) in adults and children 6 years of age and older.
  • To treat moderate to severe ulcerative colitis (UC) in adults. It is not known if IDACIO® is effective in people who stopped responding to or could not tolerate anti-TNF medicines.
  • To treat moderate to severe chronic plaque psoriasis (Ps) in adults who are ready for systemic therapy or phototherapy and are under the care of a healthcare provider who will decide if other systemic therapies are less appropriate.
  • To treat non-infectious intermediate (middle part of the eye), posterior (back of the eye), and panuveitis (all parts of the eye) in adults.

Please see the Full Prescribing Information, including the Medication Guide, for IDACIO®.

Important Safety Information About IDACIO® (adalulimab-aacf)

What is the most important information I should know about IDACIO®(adalulimab-aacf)?

You should discuss the potential benefits and risks of IDACIO® with your healthcare provider. IDACIO® is a TNF blocker medicine that affects your immune system. IDACIO® can lower the ability of your immune system to fight infections.

  • Serious infections have happened in people taking IDACIO®. These serious infections include tuberculosis (TB) and infections caused by viruses, fungi, or bacteria that have spread throughout the body. Some people have died from these infections. Your healthcare provider should test you for TB before starting IDACIO®. Your healthcare provider should check you closely for signs and symptoms of TB during treatment with IDACIO®. You should not start taking IDACIO® if you have any kind of infection unless your healthcare provider says it is okay.
  • Cancer. For children and adults taking TNF blockers, including IDACIO®, the chance of getting lymphoma or other cancers may increase. There have been cases of unusual cancers in children, teenagers, and young adults using TNF blockers. Some people have developed a rare type of cancer called hepatosplenic T-cell lymphoma. This type of cancer often results in death. If using TNF blockers including IDACIO®, your chance of getting two types of skin cancer (basal cell and squamous cell) may increase. These types are generally not life-threatening if treated; tell your healthcare provider if you have a bump or open sore that doesn’t heal.

What should I tell my healthcare provider BEFORE starting IDACIO®?

Tell your healthcare provider about all of your health conditions, including if you:

  • Have an infection, are being treated for infection, or have symptoms of an infection
  • Get a lot of infections or infections that keep coming back
  • Have diabetes
  • Have TB or have been in close contact with someone with TB
  • Live or have lived in an area (such as the Ohio and Mississippi River valleys) where there is an increased risk for getting certain kinds of fungal infections, such as histoplasmosis, coccidioidomycosis, or blastomycosis. These infections may happen or become more severe if you use IDACIO®. Ask your healthcare provider if you are unsure if you have lived in these areas
  • Have or have had hepatitis B
  • Have or had heart failure
  • Have or had cancer
  • Have any numbness or tingling or have a disease that affects your nervous system such as multiple sclerosis or Guillain-Barré syndrome.
  • Have recently received or are scheduled to receive a vaccine. You may receive vaccines, except for live vaccines. Children should be brought up to date on all vaccines before starting IDACIO®.
  • Are scheduled for major surgery
  • Are allergic to IDACIO® or to any of its ingredients.
  • Are pregnant or plan to become pregnant, breastfeeding or plan to breastfeed. You and your healthcare provider should decide if you should take IDACIO® while you are pregnant or breastfeeding.
  • Have a baby and you were using IDACIO® during your pregnancy. Tell your baby’s healthcare provider before your baby receives any vaccines.

Also tell your healthcare provider about the medications you take. You should not take IDACIO® with ORENCIA® (abatacept), KINERET® (anakinra), REMICADE® (infliximab), ENBREL® (etanercept), CIMZIA® (certolizumab pegol), or SIMPONI® (golimumab). Tell your healthcare provider if you have ever used RITUXAN® (rituximab), IMURAN® (azathioprine), or PURINETHOL® (mercaptopurine, 6-MP).

What should I watch for AFTER starting IDACIO®?

After starting IDACIO®, call your healthcare provider right away if you have an infection, or any sign of an infection. IDACIO® can make you more likely to get infections or make any infection that you may have worse.

IDACIO® can cause serious side effects, including:

  • Serious infections. Your healthcare provider will examine you for TB and perform a test to see if you have TB. If your healthcare provider feels that you are at risk for TB, you may be treated with medicine for TB before you begin treatment with IDACIO® and during treatment with IDACIO®. Even if your TB test is negative your healthcare provider should carefully monitor you for TB infections while you are taking IDACIO®. People who had a negative TB skin test before receiving adalimumab products have developed active TB. Tell your healthcare provider if you have any of the following symptoms while taking or after taking IDACIO®:
    • Cough that does not go away
    • Weight loss
    • Low grade fever
    • Loss of body fat and muscle (wasting)
  • Hepatitis B infection in carriers of the virus. If you are a carrier of the hepatitis B virus (a virus that affects the liver), the virus can become active while you use IDACIO®. Your healthcare provider should do blood tests before you start treatment, while you are using IDACIO®, and for several months after you stop treatment with IDACIO®. Tell your healthcare provider if you have any of the following symptoms of a possible hepatitis B infection:
    • Muscle aches
    • Feel very tired
    • Dark urine
    • Skin or eyes look yellow
    • Little or no appetite
    • Vomiting
    • Clay-colored bowel movements
    • Fever
    • Chills
    • Stomach discomfort
    • Skin rash
  • Allergic reactions. Allergic reactions can happen in people who use IDACIO®. Call your healthcare provider or get medical help right away if you have any of these symptoms of a serious allergic reaction:
    • Hives
    • Trouble breathing
    • Swelling of your face, eyes, lips or mouth
  • Nervous system problems. Signs and symptoms of a nervous system problem include numbness or tingling, problems with your vision, weakness in your arms or legs, and dizziness.
  • Blood problems. Your body may not make enough of the blood cells that help fight infections or help to stop bleeding. Symptoms include a fever that does not go away, bruising or bleeding very easily, or looking very pale.
  • Heart Failure (new or worsening) Symptoms include shortness of breath, swelling of your ankles or feet, and sudden weight gain.
  • Immune reactions including a lupus-like syndrome. Symptoms include chest discomfort or pain that does not go away, shortness of breath, joint pain, or a rash on your cheeks or arms that gets worse in the sun. Symptoms may improve when you stop IDACIO®.
  • Liver problems. Liver problems can happen in people who use TNF-blocker medicines. These problems can lead to liver failure and death. Call your healthcare provider right away if you have any of these symptoms:
    • Feel very tired
    • Poor appetite or vomiting
    • Skin or eyes look yellow
    • Pain on the right side of your stomach (abdomen)
  • Psoriasis. Some people using adalimumab products had new psoriasis or worsening of psoriasis they already had. Tell your healthcare provider if you develop red scaly patches or raised bumps that are filled with pus. Your healthcare provider may decide to stop your treatment with IDACIO®.

Call your healthcare provider or get medical care right away if you develop any of the above symptoms. Your treatment with IDACIO® may be stopped.

Common side effects of IDACIO® include injection site reactions (pain, redness, rash, swelling, itching, or bruising), upper respiratory infections (sinus infections), headaches, rash, and nausea. These are not all the possible side effects with IDACIO®. Tell your doctor if you have any side effect that bothers you or that does not go away.

These are not all the possible side effects with IDACIO®. Tell your healthcare provider if you have any side effect that bothers you or that does not go away.

Remember, tell your doctor right away if you have an infection or symptoms of an infection, including:

  • Fever, sweats, or chills
  • Muscle aches
  • Cough
  • Shortness of breath
  • Blood in phlegm
  • Weight loss
  • Warm, red, or painful skin or sores on your body
  • Diarrhea or stomach pain
  • Burning when you urinate
  • Urinating more often than normal
  • Feeling very tired

IDACIO® is given by injection under the skin.

This is the most important information to know about IDACIO®. For more information, talk to your health care provider.

Uses

IDACIO®is a prescription medicine used:

  • To reduce the signs and symptoms of:
    • Moderate to severe rheumatoid arthritis (RA) in adults. IDACIO® can be used alone, with methotrexate, or with certain other medicines. IDACIO® may prevent further damage to your bones and joints and may help your ability to perform daily activities.
    • Moderate to severe polyarticular juvenile idiopathic arthritis (JIA) in children 2 years of age and older. IDACIO® can be used alone or with methotrexate.
    • Psoriatic arthritis (PsA) in adults. IDACIO® can be used alone or with certain other medicines. IDACIO® may prevent further damage to your bones and joints and may help your ability to perform daily activities.
    • Ankylosing spondylitis (AS) in adults.
    • Hidradenitis Suppurativa (HS): treatment of moderate to severe hidradenitis suppurativa in adults.
  • To treat moderate to severe Crohn’s disease (CD) in adults and children 6 years of age and older.
  • To treat moderate to severe ulcerative colitis (UC) in adults. It is not known if IDACIO® is effective in people who stopped responding to or could not tolerate anti-TNF medicines.
  • To treat moderate to severe chronic plaque psoriasis (Ps) in adults who are ready for systemic therapy or phototherapy and are under the care of a healthcare provider who will decide if other systemic therapies are less appropriate.
  • To treat non-infectious intermediate (middle part of the eye), posterior (back of the eye), and panuveitis (all parts of the eye) in adults.

Please see the Full Prescribing Information, including the Medication Guide, for IDACIO®.